As part of our coverage of ONS, we discuss dermatologic issues in oncology patients, including skin-related toxicities and assessment techniques used to identify skin-related issues.
Krista M. Rubin, MS, RN
Advertisement
Articles by Krista M. Rubin, MS, RN
Melanoma affects persons of all ages, causing more years of lost life than any other cancer except leukemia.[1] The American Cancer Society estimates that about 68,720 new melanomas will be diagnosed in the US in 2009, with more than 8,650 deaths, and an estimated lifetime risk of 1 in 50 for whites, 1 in 200 for Hispanics, and 1 in 1,000 for blacks.[2]
Advertisement
Latest Updated Articles
Your Patient With Melanoma: Staging, Prognosis, and TreatmentPublished: August 5th 2009 | Updated:
Nurses Play Important Part in Recognizing Skin Toxicities, AbnormalitiesPublished: April 27th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
